At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vis-Rx Prime Micro-Imaging Catheter Clinical Evaluation Study
In Brief
An observational study for Coronary Artery Disease. Completed, enrolled 34 participants across 3 sites.
Detailed Summary
To study the performance of the Gentuity® HF-OCT (High Frequency Optical Coherence Tomography) Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter use by physicians using the catheters, image quality and overall performance. The patient's involvement in the study ends when the cardiac catheterization/interventional procedure is completed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedNov 2024
Enrollment StartDec 2024
Primary CompletionApr 2025
Study CompletionMay 2025
TodayJul 2026
First PostedNov 12, 2024
Enrollment StartDec 11, 2024
Primary CompletionApr 30, 2025
Study CompletionMay 1, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.6 years ago